ResultsIQ › Latest results › Neuland Laboratories Limited
Neuland Laboratories Limited Q2 FY27 results press release summary
NSE: NEULANDLAB · BSE: 524558
Results press release of 3 Nov 2026, summarised by AI from the filing.
Growth expectations remain intact for FY27 and the following year, with H1 FY27 largely in line with plan.
Key takeaways
- Guidance Growth expectations remain intact for FY27 and the following year, with H1 FY27 largely in line with plan.
- Driver Commercial CMS projects contributed the majority share of revenue and continue to drive near-term growth.
- Risk Revenue and margin declined this quarter, which management attributes to operating deleverage.
Neuland Laboratories Limited Q2 FY27 results
As filed: Revenue ₹450 cr (−13% year on year), EBITDA ₹97.6 cr (−37% year on year), PAT ₹51.6 cr (−47% year on year), EBITDA margin 21.7% (−846 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹642 cr (+119% year on year), EBITDA ₹223 cr (+300% year on year), PAT ₹148 cr (+300% year on year), EBITDA margin 34.7% (+1,000 bps). Score 85 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue fell 17% from last quarter. Share price after the results: +13.5% in 30 days (Nifty 500: −2.0%).
- Q4 FY26: Revenue ₹776 cr (+137% year on year), EBITDA ₹307 cr (+300% year on year), PAT ₹213 cr (+300% year on year), EBITDA margin 39.6% (+1,000 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −0.2% in 30 days (Nifty 500: −0.8%).
- Q3 FY26: Revenue ₹440 cr (+10% year on year), EBITDA ₹77.1 cr (−10% year on year), PAT ₹40.6 cr (−60% year on year), EBITDA margin 17.5% (−406 bps). Score 44 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was below it. EBITDA margin fell 406 bps year on year. Revenue fell 14% from last quarter. Share price after the results: −7.6% in 30 days (Nifty 500: −6.9%).
- Q2 FY26: Revenue ₹514 cr (+65% year on year), EBITDA ₹155 cr (+150% year on year), PAT ₹97.0 cr (+194% year on year), EBITDA margin 30.2% (+1,000 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −5.3% in 28 days (Nifty 500: +1.3%).
- Q1 FY26: Revenue ₹293 cr (−33% year on year), EBITDA ₹35.0 cr (−72% year on year), PAT ₹14.0 cr (−86% year on year), EBITDA margin 12.0% (−1,000 bps). Score 15 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Other income 44% of PBT. Revenue fell 11% from last quarter. Share price after the results: +1.3% in 29 days (Nifty 500: −2.0%).
- Q4 FY25: Revenue ₹328 cr (−15% year on year), EBITDA ₹51.0 cr (−52% year on year), PAT ₹28.0 cr (−59% year on year), EBITDA margin 15.6% (−1,000 bps). Score 28 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend; profit growth was well below it. EBITDA margin fell 1000 bps year on year. Revenue fell 18% from last quarter. Share price after the results: +11.2% in 29 days (Nifty 500: +0.5%).
- Q3 FY25: Revenue ₹398 cr (+1% year on year), EBITDA ₹86.0 cr (−29% year on year), PAT ₹102 cr (−31% year on year), EBITDA margin 21.6% (−918 bps). Score 36 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were below it. EBITDA margin fell 918 bps year on year.
Past price moves after results do not indicate future moves. Not a recommendation.
Neuland Laboratories Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (3 Nov 2026), Results deck (3 Nov 2026), Results press release (3 Nov 2026)
- Q1 FY27: Earnings call (5 Aug 2026), Results deck (5 Aug 2026), Results press release (5 Aug 2026)
- Q4 FY26: Earnings call (12 May 2026), Results deck (12 May 2026), Results press release (12 May 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (9 Feb 2026), Results press release (9 Feb 2026)
- Q2 FY26: Earnings call (7 Nov 2025), Results deck (7 Nov 2025), Results press release (7 Nov 2025)
- Q1 FY26: Earnings call (31 Jul 2025), Results deck (31 Jul 2025), Results press release (31 Jul 2025)
- Q4 FY25: Earnings call (15 May 2025), Results deck (15 May 2025), Results press release (15 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.